SCHEMBL231848

SCHEMBL231848

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC(=O)[C@]12C

nearest known ligand 0.75

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 13/20 0.75
NR1H4 Q96RI1 3/20 0.75
MEN1 O00255 2/20 0.75
KMT2A Q03164 2/20 0.75
ABCB11 O95342 2/20 0.75
SLC10A2 Q12908 2/20 0.75
CYP3A4 P08684 2/20 0.75
LMNA P02545 2/20 0.75
CYP2C19 P33261 1/20 0.75
CHRM2 P08172 1/20 0.75
ADRA2A P08913 1/20 0.75
ADRA1A P35348 1/20 0.75
TDP1 Q9NUW8 1/20 0.75
ENPP2 Q13822 1/20 0.75
SLC10A1 Q14973 1/20 0.75
CISD1 Q9NZ45 1/20 0.75
PDE3A Q14432 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1071844 1.00 GPBAR1 (0.75) GPBAR1NR1H4MEN1KMT2AABCB11
SCHEMBL1931918 1.00 GPBAR1 (0.75) GPBAR1NR1H4MEN1KMT2AABCB11
SCHEMBL19697632 1.00 GPBAR1 (0.75) GPBAR1NR1H4MEN1KMT2AABCB11
SCHEMBL8659794 1.00 GPBAR1 (0.75) GPBAR1NR1H4MEN1KMT2AABCB11
SCHEMBL24408031 1.00 GPBAR1 (0.75) GPBAR1NR1H4MEN1KMT2AABCB11
SCHEMBL8435259 1.00 GPBAR1 (0.75) GPBAR1NR1H4MEN1KMT2AABCB11
SCHEMBL24999988 1.00 GPBAR1 (0.75) GPBAR1NR1H4MEN1KMT2AABCB11
SCHEMBL18827757 1.00 GPBAR1 (0.75) GPBAR1NR1H4MEN1KMT2AABCB11
SCHEMBL24001462 1.00 GPBAR1 (0.75) GPBAR1NR1H4MEN1KMT2AABCB11
SCHEMBL16361266 1.00 GPBAR1 (0.75) GPBAR1NR1H4MEN1KMT2AABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240068007-A1 BIOMARKERS OF RISK FOR INFECTION THE UNIVERSITY OF CHICAGO 2024-02-29 US claimed
US-20240058454-A1 BIOLOGICAL DELIVERY SYSTEMS PARTICELLA INC (US) 2024-02-22 US claimed
CN-117241780-A Biological delivery system 帕帝塞拉公司 2023-12-15 CN claimed
CN-116445434-A 12 alpha-HSDH enzyme mutant with improved catalytic activity and application thereof 中山百灵生物技术股份有限公司 2023-07-18 CN claimed
US-11634743-B2 Coupled, self-sufficient biotransformation of chenodeoxcholic acid to ursodeoxycholic acid and novel enzyme mutants applicable in said process PHARMAZELL GMBH (DE) 2023-04-25 US claimed
CN-113960222-B Serum sample-based bile acid full-channel metabolic profile detection method and application thereof 中国中医科学院医学实验中心 2022-02-25 CN claimed
CN-113960221-B Method for detecting bile acid full-channel metabolic profile based on fecal sample and application thereof 中国中医科学院医学实验中心 2022-02-25 CN claimed
CN-113960222-A Serum sample-based bile acid full-channel metabolic profile detection method and application thereof 中国中医科学院医学实验中心 2022-01-21 CN claimed
CN-113960221-A Method for detecting bile acid full-channel metabolic profile based on fecal sample and application thereof 中国中医科学院医学实验中心 2022-01-21 CN claimed
US-20200407766-A1 Coupled, Self-Sufficient Biotransformation of Chenodeoxcholic Acid to Ursodeoxycholic Acid and Novel Enzyme Mutants Applicable in said Process PHARMAZELL GMBH (DE) 2020-12-31 US claimed
EP-2576600-B1 NOVEL 7ALPHA-HYDROXYSTEROID DEHYDROGENASE KNOCKOUT MUTANTS AND USE THEREOF PHARMAZELL GMBH (DE) 2018-01-24 EP claimed
WO-2017220486-A2 COUPLED, SELF-SUFFICIENT BIOTRANSFORMATION OF CHENODEOXYCHOLIC ACID TO URSODEOXYCHOLIC ACID AND NOVEL ENZYME MUTANTS APPLICABLE IN SAID PROCESS PHARMAZELL GMBH (DE) 2017-12-28 WO claimed
US-9096825-B2 7 α-hydroxysteroid dehydrogenase knockout mutants and use therefor PHARMAZELL GMBH (DE) 2015-08-04 US claimed
US-20140147887-A1 NOVEL 12 ALPHA-HYDROXYSTEROID DEHYDROGENASES, PRODUCTION AND USE THEREOF PHARMAZELL GMBH (DE) 2014-05-29 US claimed
US-20130224792-A1 Novel 7 alpha-Hydroxysteroid Dehydrogenase Knockout Mutants and Use Therefor PHARMAZELL GMBH (DE) 2013-08-29 US claimed
US-7851174-B2 Method for quantitatively determining cholesterol in high density lipoproteins and reagents therefor KYOWA MEDEX CO., LTD. (JP) 2010-12-14 US claimed
US-20090226944-A1 METHOD FOR MEASURING TRIGLYCERIDE IN LOW-DENSITY LIPOPROTEIN AND KIT FOR MEASUREMENT KYOWA MEDEX CO., LTD. (JP) 2009-09-10 US claimed
EP-1953240-A1 METHOD FOR MEASURING TRIGLYCERIDE IN LOW-DENSITY LIPOPROTEIN AND KIT FOR MEASUREMENT Kyowa Medex Co., Ltd. (JP) 2008-08-06 EP claimed
US-20050287619-A1 Method and reagent for measuring cholesterol in high-density lipoproteins KYOWA MEDEX CO., LTD. (JP) 2005-12-29 US claimed
EP-1555327-A1 METHOD AND REAGENT FOR MEASURING CHOLESTEROL IN HIGH-DENSITY LIPOPROTEINS Kyowa Medex Co., Ltd. (JP) 2005-07-20 EP claimed